Fertility and sterility
-
Fertility and sterility · Nov 2019
Randomized Controlled Trial Multicenter StudyRelugolix, a novel oral gonadotropin-releasing hormone antagonist, in the treatment of pain symptoms associated with uterine fibroids: a randomized, placebo-controlled, phase 3 study in Japanese women.
To investigate the efficacy and safety of the oral gonadotropin-releasing hormone receptor antagonist, relugolix, in patients experiencing uterine fibroid-associated pain. ⋯ JapicCTI-163127.